Wenghuan Feng

Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non‐alcoholic fatty liver disease: A randomized trial

Dalong Zhu, Y. Bi, S. Shen, 2018, Journal of diabetes investigation.

A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels

Dalong Zhu, Xitai Sun, Y. Bi, 2019, BMC Gastroenterology.

Correlated increase of omentin-1 and adiponectin by exenatide, avandamet and dietary change in diet-induced obese rats.

Y. Bi, G. Tong, S. Shen, 2013, Folia biologica.

Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial

Dalong Zhu, Y. Bi, S. Shen, 2018, Nutrition & Metabolism.

Oxygen therapy alleviates hepatic steatosis by inhibiting hypoxia-inducible factor-2α.

Jinhui Wu, Dalong Zhu, Y. Bi, 2020, The Journal of endocrinology.

Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non‐alcoholic fatty liver disease: A randomized trial

Dalong Zhu, Y. Bi, S. Shen, 2018, Journal of diabetes investigation.